YIDA CHINA (03639): The requesting hearing date is further postponed to January 20, 2025, and the suspension continues.
Yida China (03639) announced that the scheduled hearing date has been postponed to November 18, 2024. According to...
YIDA CHINA (03639) announced that the scheduled hearing date has been postponed to November 18, 2024. According to the notice from the High Court, the hearing date has been further postponed to January 20, 2025.
In addition, trading of the company's shares will remain suspended.
Related Articles

Southwest: The driver gene-negative NSCLC market has broad space, with both dual (or multiple) antibody and IO+ADC schemes advancing side by side.

HK Stock Market Move | EDGE MEDICAL-B(02675) rose more than 12% in the afternoon, with the company's domestic sales ranking first among manufacturers and overseas orders experiencing explosive growth.

HK Stock Market Move | STANCHART(02888) fell more than 6% at one point, and Chief Financial Officer Diego De Giorgi resigned to take an external job opportunity.
Southwest: The driver gene-negative NSCLC market has broad space, with both dual (or multiple) antibody and IO+ADC schemes advancing side by side.

HK Stock Market Move | EDGE MEDICAL-B(02675) rose more than 12% in the afternoon, with the company's domestic sales ranking first among manufacturers and overseas orders experiencing explosive growth.

HK Stock Market Move | STANCHART(02888) fell more than 6% at one point, and Chief Financial Officer Diego De Giorgi resigned to take an external job opportunity.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


